000 01508 a2200409 4500
005 20250515031047.0
264 0 _c20070201
008 200702s 0 0 eng d
022 _a0923-7534
024 7 _a10.1093/annonc/mdl124
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFerreri, A J M
245 0 0 _aBacteria-eradicating therapy for ocular adnexal MALT lymphoma: questions for an open international prospective trial.
_h[electronic resource]
260 _bAnnals of oncology : official journal of the European Society for Medical Oncology
_cNov 2006
300 _a1721-2 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aAnti-Bacterial Agents
_xpharmacology
650 0 4 _aBacteria
_xdrug effects
650 0 4 _aChlamydia
_xdrug effects
650 0 4 _aClinical Trials as Topic
650 0 4 _aDoxycycline
_xpharmacology
650 0 4 _aEndpoint Determination
650 0 4 _aEye Neoplasms
_xdrug therapy
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aLymphoma, B-Cell, Marginal Zone
_xdrug therapy
650 0 4 _aProspective Studies
700 1 _aPonzoni, M
700 1 _aDognini, G P
700 1 _aDu, M-Q
700 1 _aDoglioni, C
700 1 _aRadford, J
700 1 _aDolcetti, R
700 1 _aCavalli, F
773 0 _tAnnals of oncology : official journal of the European Society for Medical Oncology
_gvol. 17
_gno. 11
_gp. 1721-2
856 4 0 _uhttps://doi.org/10.1093/annonc/mdl124
_zAvailable from publisher's website
999 _c16356158
_d16356158